PTC Therapeutics, Inc. (PTCT)
70.72
+3.07
(+4.54%)
USD |
NASDAQ |
May 27, 15:53
PTC Therapeutics Cash from Investing (Quarterly) : -93.74M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -134.39M |
| Keros Therapeutics, Inc. | -0.073M |
| Insmed, Inc. | 265.52M |
| Madrigal Pharmaceuticals, Inc. | 192.19M |
| Protagonist Therapeutics, Inc. | 90.89M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -59.04M |
| Cash from Financing (Quarterly) | 6.403M |
| Free Cash Flow | -516.78M |
| Free Cash Flow Per Share (Quarterly) | -0.7319 |
| Free Cash Flow to Equity (Quarterly) | -56.78M |
| Free Cash Flow to Firm (Quarterly) | -4.455M |
| Free Cash Flow Yield | -8.90% |